Association of Persistent Pulmonary Hypertension in Infants With the Timing and Type of Antidepressants In Utero

Authors:

Abstract
Antidepressant exposure during pregnancy has been linked to increased risk of persistent pulmonary hypertension of the newborn (PPHN).1 Risks of PPHN have been explored for different types of selective serotonin reuptake inhibitors (SSRIs). However, risks after non-SSRI exposure and risks with timing of exposure in pregnancy across type of antidepressants have been insufficiently quantified or evidence remains conflicting.2,3 Given that PPHN is a potentially lethal complication, more detailed information on trimester- and antidepressant type–specific risk is essential.

This publication has 5 references indexed in Scilit: